KPV
What is KPV?
KPV (Lysine–Proline–Valine) is a naturally occurring tripeptide known for its strong anti-inflammatory effects. It works by interacting with melanocortin 1 receptors (MC1R) to inhibit key inflammatory pathways, including the suppression of cytokines like TNF-α, IL-6, and NF-κB. Unlike traditional anti-inflammatory drugs, KPV has shown the ability to reduce inflammation without broadly suppressing the immune system. Research has explored its therapeutic potential in conditions affecting the gut, skin, and other tissues where localized inflammation plays a role, making it a promising candidate for immune modulation and tissue recovery.
Potential Benefits Shown in Studies
Potential Benefits Shown in Studies – KPV
- Reduces inflammation by suppressing pro-inflammatory cytokines (e.g., TNF-α, IL-6)
- Modulates immune response without broad immunosuppression
- Calms inflammation in the gut, including models of colitis and IBD
- Supports skin healing and reduces inflammatory skin conditions
- Acts through melanocortin receptors to target localized inflammation
- May help protect tissues from chronic inflammatory damage
- Potential use in systemic and localized inflammatory conditions
Mechanisms of Action
Mechanism of Action – KPV
- Melanocortin Receptor Activation: Binds primarily to melanocortin 1 receptors (MC1R), which play a key role in regulating inflammation.
- NF-κB Inhibition: Suppresses nuclear factor kappa B (NF-κB), a central transcription factor involved in inflammatory cytokine production.
- Cytokine Modulation: Downregulates pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β.
- Localized Anti-Inflammatory Effects: Reduces inflammation at the tissue level without broadly suppressing systemic immune function.
- Supports Barrier Integrity: May help maintain epithelial barrier function in gut and skin by reducing inflammatory stress.
Research Highlights
Anti inflammatory
Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway
Skin benefits
Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin
Gut Health
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon
Molecular Structure

